Multifunctional radiolabeled nanoparticles for targeted therapy

G Ferro-Flores, BE Ocampo-García… - Current medicinal …, 2014 - ingentaconnect.com
Nanoparticles can be near infrared (NIR)-fluorescent (eg, gold nanoparticles, quantum dots
or carbon nanotubes) or can have magnetic properties (eg, iron oxide nanoparticles). These …

Active-targeted nanotherapy strategies for prostate cancer

M Katsogiannou, L Peng… - Current cancer drug …, 2011 - ingentaconnect.com
Castration-resistant prostate cancer remains incurable and a major cause of mortality
worldwide. The absence of effective therapeutic approaches for advanced prostate cancer …

177Lu‐labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing α(ν)β(3) integrins

M Luna‐Gutiérrez, G Ferro‐Flores… - Journal of Labelled …, 2012 - Wiley Online Library
The conjugation of peptides to gold nanoparticles (AuNPs) produces biocompatible and
stable multimeric systems with target‐specific molecular recognition. Peptides based on the …

Bombesin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

J Battey, RV Benya, RT Jensen… - IUPHAR/BPS Guide to …, 2019 - journals.ed.ac.uk
Mammalian bombesin (Bn) receptors comprise 3 subtypes: BB 1, BB 2, BB 3 (nomenclature
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[109]). BB 1 and …

Multifunctional targeted radiotherapy system for induced tumours expressing gastrin-releasing peptide receptors

N Jimenez-Mancilla, G Ferro-Flores… - Current …, 2012 - ingentaconnect.com
The gastrin-releasing peptide receptor (GRP-r) is overexpressed in breast and prostate
cancer, and Lys3-bombesin is a peptide that binds with high affinity to the GRP-r. HIV Tat (49 …

Evaluation of a new radiolabeled bombesin derivative with 99mTc as potential targeted tumor imaging agent

N Sadeghzadeh, M Ahmadzadeh, M Erfani - Journal of radioanalytical …, 2013 - Springer
Gastrin-releasing peptide (GRP) receptors are over-expressed in various human tumor
including breast and prostate which can be targeted with bombesin for diagnosis and …

Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models

PB Pujatti, JM Foster, C Finucane, CD Hudson… - Applied Radiation and …, 2015 - Elsevier
We evaluated and compared a new bombesin analog [Tyr–Gly 5, Nle 14]-BBN (6–14)
conjugated to DOTA or DTPA and radiolabeled with In-111 in low and high GRPR …

Preparation of [In-111]-labeled-DTPA-bombesin conjugates at high specific activity and stability: Evaluation of labeling parameters and potential stabilizers

PB Pujatti, AVF Massicano, J Mengatti… - Applied Radiation and …, 2012 - Elsevier
The aim of the present work was to obtain stabilized high specific activity (HSA) 111In-
labeled bombesin conjugates for preclinical evaluations. Parameters influencing the kinetics …

Bombesin receptors in GtoPdb v. 2021.2

J Battey, RV Benya, RT Jensen… - IUPHAR/BPS Guide to …, 2021 - journals.ed.ac.uk
Mammalian bombesin (Bn) receptors comprise 3 subtypes: BB 1, BB 2, BB 3 (nomenclature
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[115]). BB 1 and …

Radiolabeling efficiency and stability study on Lutetium-177 labeled bombesin peptide

B Jowanaridhi, W Sriwiang - Journal of Physics: Conference …, 2019 - iopscience.iop.org
Bombesin is a 14-amino-acid peptide having the ability to specifically bind gastrin releasing
peptide receptors (GRPR) which show over-expression in many types of cancer cells …